科研成果详情

名称Myelofibrosis predicts deep molecular response 4.5 in chronic myeloid leukaemia patients initially treated with imatinib: An extensive, multicenter and retrospective study to develop a prognostic model
作者
Tian Zeng1,2,3; Xiudi Yang1,2,3; Yi Wang3,4; Dijiong Wu3,5; Weiying Feng3,6; Ying Lu3,7; Xiaoqiong Zhu2,3,8; Lirong Liu3,9; Mei Zhou3,10; Li Zhang3,11; Yanping Shao3,11; Honglan Qian3,12; Feng Zhu3,13; Yu Chen3,14; Dan Cao3,15; Li Huang3,16; Xiaoning Feng3,17; Lili Chen3,18; Gang Zhang3,19; Jing Le3,20; Weiguo Zhu3,21; Yongming Xia3,22; Yanxia Han3,23; Yongqing Jia3,24; Guoyan Tian3,25; Hui Zhou3,25; Linjuan Xu3,26; Xiufeng Yin3,27; Qinli Tang3,28; Yuefeng Zhang3,29; Guoli Yao3,29; Xianghua Lang3,30; Kaifeng Zhang3,31; Xiujie Zhou3,32; Junbin Guo3,33; Jinming Tu3,34; Jianzhi Zhao3,35; Gongqiang Wu3,36; Huiqi Zhang3,37; Xiao Wu3,38; Qiulian Luo3,39; Lihong Cao3,40; Binbin Chu3,41; Wei Jiang3,42; Haiying Wu3,43; Liansheng Huang3,44; Meiwei Hu3,45; Muqing He3,46; Jingjing Zhu1,2,3; Hongyan Tong1,2,3; Jie Jin1,2,3; Jian Huang1,2,3
发表期刊Clinical and translational medicine
语种英语
原始文献类型Letter
资助项目Key R&D Program of Zhejiang[2022C03137];Zhejiang Medical Association Clinical Medical Research Special Fund Project[2022ZYC-D09]
ISSN2001-1326
卷号14
期号11
DOI10.1002/ctm2.70101
收录类别PUBMED
发布日期2024-11
URL查看原文
PubMed ID39576229
引用统计
文献类型其他
条目标识符https://kms.wmu.edu.cn/handle/3ETUA0LF/221709
专题附属第一医院
温州医科大学
附属第二医院_儿童血液科
其他_附属东阳医院(东阳市人民医院)
其他_温州医科大学附属衢州医院
作者单位
1.Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.;
2.Zhejiang Clinical Medical Research Center of Hematology, Hangzhou, China.;
3.CML Cooperation Group of Zhejiang Hematology, Zhejiang, China.;
4.Department of Hematology, The First Affiliated Hospital of Ningbo University, Ningbo, China.;
5.Department of Hematology, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China.;
6.Department of Hematology, Shaoxing People's Hospital, Shaoxing, China.;
7.Department of Hematology, The Affiliated People's Hospital of Ningbo University, Ningbo, China.;
8.Department of Hematology, The Fourth Affiliated Hospital, Zhejiang University School of Medicine, YiWu, China.;
9.Department of Hematology, The Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, China.;
10.Department of Hematology, Zhuji Affiliated Hospital of Shaoxing University, Shaoxing, China.;
11.Department of Hematology, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Taizhou, China.;
12.Department of Hematology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.;
13.Department of Hematology, Zhoushan Hospital, Zhejiang University School of Medicine, Zhoushan, China.;
14.Department of Hematology, College of Medicine, Lishui Hospital, Zhejiang University, Lishui, China.;
15.Department of Hematology, Huzhou Central Hospital, Huzhou, China.;
16.Department of Hematology, The Affiliated Jinhua Hospital of Wenzhou Medical University, Jinhua, China.;
17.Department of Hematology, Lishui People's Hospital, Lishui, China.;
18.Department of Hematology, The First People's Hospital of Taizhou, Taizhou, China.;
19.Department of Hematology, The First Hospital of Jiaxing, The Affiliated Hospital of Jiaxing University, Jiaxing, China.;
20.Department of Hematology, Ningbo Medical Center Lihuili Hospital, Ningbo, China.;
21.Department of Hematology, Shaoxing Second Hospital, Shaoxing, China.;
22.Department of Hematology, The Affiliated Yangming Hospital of Ningbo University, Yuyao People's Hospital of Zhejiang Province, Yuyao, China.;
23.Department of Hematology, The Second Hospital of Jiaxing, Jiaxing, China.;
24.Department of Hematology, Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, China.;
25.Department of Hematology, The Affiliated Hospital of Hangzhou Normal University, Hangzhou, China.;
26.Department of Hematology, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzhou, China.;
27.Department of Hematology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.;
28.Department of Hematology, The First People's Hospital of PingHu, PingHu, China.;
29.Department of Hematology, First People's Hospital of Linping District, Hangzhou, China.;
30.Department of Hematology, Yongkang First People's Hospital Affiliated to Hangzhou Medical College, Yongkang, China.;
31.Department of Hematology, Xinchang County People's Hospital, Xinchang, China.;
32.Department of Hematology, Haining People's Hospital, Haining, China.;
33.Department of Hematology, The First People's Hospital Of Wenling, Wenling, China.;
34.Department of Hematology, The People's Hospital of Longyou City, Longyou, China.;
35.Department of Hematology, Shaoxing Central Hospital, Shaoxing, China.;
36.Department of Hematology, Dongyang Hospital Affiliated to Wenzhou Medical University, Dongyang People's Hospital, Dongyang, China.;
37.Department of Hematology, The First People's Hospital of Huzhou, Huzhou, China.;
38.Department of Hematology, The Affiliated Hospital of Medical School, Ningbo University, Ningbo, China.;
39.Department of Hematology, Yiwu Central Hospital, Yiwu, China.;
40.Department of Hematology, Shulan (Hangzhou) Hospital Affiliated to Zhejiang Shuren University Shulan International Medical College, Hangzhou, China.;
41.Department of Hematology, Oncology Ningbo Mingzhou Hospital, Ningbo, China.;
42.Department of Hematology, Shangyu People's Hospital of Shaoxing, Shaoxing, China.;
43.Department of Hematology, Tongde Hospital of Zhejiang Province, Hangzhou, China.;
44.Department of Hematology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.;
45.Department of Hematology, The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China.;
46.Department of Hematology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
推荐引用方式
GB/T 7714
Tian Zeng,Xiudi Yang,Yi Wang,et al. Myelofibrosis predicts deep molecular response 4.5 in chronic myeloid leukaemia patients initially treated with imatinib: An extensive, multicenter and retrospective study to develop a prognostic model. 2024.

条目包含的文件

条目无相关文件。
个性服务
查看访问统计
谷歌学术
谷歌学术中相似的文章
[Tian Zeng]的文章
[Xiudi Yang]的文章
[Yi Wang]的文章
百度学术
百度学术中相似的文章
[Tian Zeng]的文章
[Xiudi Yang]的文章
[Yi Wang]的文章
必应学术
必应学术中相似的文章
[Tian Zeng]的文章
[Xiudi Yang]的文章
[Yi Wang]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。